Aidence
AI detection of lung nodules on CT scans for earlier diagnosis
Healthcare · Rotterdam · Founded 2015
- Founded
- 2015
- Total raised
- €13.2M
- Latest round
- Other
- Location
- Rotterdam
What is being written
In the media
What they build
Overview
Aidence develops AI-powered clinical applications that empower healthcare and pharmaceutical professionals in the lung cancer pathway. Their flagship product, Veye Lung Nodules, is a CE-certified deep learning solution for automated detection, quantification, and tracking of pulmonary nodules on chest CTs. They also offer Veye Reporting for standardized quality reporting. The company's mission is to deliver faster, more precise diagnostics and treatments, improving early detection and treatment response assessment for lung cancer patients.
Who believes in them
Investors & funding
Aidence raised €13.2M in total. The latest known round is Other.
Where they are
Location
Nearby
Loading nearby…
Address
Rotterdam · South HollandNo exact address
Frequently asked questions
Frequently asked questions
What does Aidence do?
AI detection of lung nodules on CT scans for earlier diagnosis
What sector is Aidence in?
Aidence operates in Healthcare.
Where is Aidence based?
Aidence is based in Rotterdam, South Holland.
When was Aidence founded?
Aidence was founded in 2015.
How much funding has Aidence raised?
Aidence has raised €13.2M in funding in total.
Keep exploring